β-arrestin 1 can alter insulin signaling by inhibiting insulin-induced proteasomal degradation of IRS-1 and the inhibition of beta-arrestin-1 leads to enhanced IRS-1 degradation and accentuated cellular insulin resistance [148]. Here, INS is linked to Insulin resistance.